Compared to CD27+IgG- B cells, the CD27+IgG+ B cells markedly elevated expression of IFN-γ, which was consistent with our finding that CD27 on PB/PC reduces the risk of breast cancer. The gene discussed is IFNG; the disease is breast carcinoma.